Dana P. Goldman

Dana P. Goldman, PhD

Leonard D. Schaeffer Director's Chair, USC Schaeffer Center for Health Policy and Economics
Distinguished Professor of Public Policy, Pharmacy and Economics

Pharmaceutical and Health Economics

Contact Information


PhD, Economics, Stanford University
BA, Summa Cum Laude, Cornell University

Dana P. Goldman


Dana Goldman is the Leonard D. Schaeffer Chair and a Distinguished Professor of Pharmacy, Public Policy, and Economics at the University of Southern California. He also directs the Schaeffer Center for Health Policy and Economics, which servves as the research and policy hub for USC's health policy and management programs (ranked #3 in 2016 by US News & World Report).

Dr. Goldman is the author of over 200 articles and book chapters, and his research has been published in leading medical, economic, health policy, and statistics journals. He is a health policy advisor to the Congressional Budget Office, Covered California (the California insurance exchange), the Fred Hutchinson Cancer Institute, and is a frequent speaker on health care issues. He is a founding editor of the Forum for Health Economics and Policy, and serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is a member of the board of directors for the International Society for Pharmacoeconomics and Outcomes Research and the American Society of Health Economists. Dr. Goldman's work has been featured in the New York Times, Wall Street Journal, Washington Post, Business Week, U.S. News and World Report, The Economist, NBC Nightly News, CNN, National Public Radio, and other media.

Dr. Goldman has received several prominent awards. In 2016, he was appointed a Distinguished Professor at USC and in 2009 he was elected to the National Academy of Medicine (formerly the Institute of Medicine). He also was a recipient of the MetLife Foundation Silver Scholar Award, honoring his research to define the value of healthy aging and medical innovations to help individuals live healthier and longer lives; the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy; the National Institute for Health Care Management Research Foundation award for excellence in health policy; and the Alice S. Hersh New Investigator Award recognizing contributions of a young scholar to the field of health services research.

Dr. Goldman is also an Adjunct Professor of Health Services at UCLA and a research associate with the National Bureau of Economic Research. Prior to 2009, he held the Distinguished Chair in Health Economics at the RAND Corporation and was the director of RAND's program in Health Economics, Finance, and Organization and the Bing Center for Health Economics. He also is a co-founder of Precision Health Economics, a health economics consultancy to the life sciences industry.

He received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.

Selected Projects/Publications

View a complete PubMed search

View a complete Google Scholar search

The link between public and private insurance and HIV-related mortality (with Neeraj Sood and Jayanta Bhattacharya), Journal of Health Economics (2003)

Forecasting the Nursing Home Population (with Darius Noshir Lakdawalla, Jay Bhattacharya, Michael Hurd, Geoffrey Joyce, and Constantijn Panis), Medical Care (2003) -Link

Using Hospital Tumor Registries to Identify Research Subjects (with Michael Schoenbaum, Meredith L. Kilgore, Beverly A. Weidmer, Sandra H. Berry, Jose J. Escarce, Joy H. Lewis, and Nikhil Wagle), Health Services and Outcomes Research Methodology (2006) -Link

Sampling Patients Within and Across Health Care Providers: Multi-Stage Non-Nested Samples in Health Services Research (with John L. Adams, Matthias Schonlau, Jose J. Escarce, Meredith Kilgore, and Schoenbaum Schoenbaum), Health Services and Outcomes Research Methodology (2006) -Link

Estimating Probit Models with Self-Selected Treatments (with Jay Bhattacharya and Daniel McCaffrey), Statistics in Medicine (2006) -Link

The Costs of A Medicare Prescription Drug Benefit (with Geoffrey F. Joyce and Jesse Dylan Malkin), Topics in Economic Analysis & Policy (2000) -Link

Employer Drug Benefit Plans and Spending on Prescription Drugs (with Geoffrey F. Joyce, Jose J. Escarce, and Matthew D. Solomon), Journal of the American Medical Association (2002) -Link

The Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials (with Joy H. Lewis, Meredith L. Kilgore, Edward L. Trimble, Richard Kaplan, Michael J. Montello, Michael G. Housman, and Jose J. Escarce), Journal of Clinical Oncology (2003) -Link

High Out-Of-Pocket Health Care Spending By The Elderly (with Julie M. Zissimopoulos), Health Affairs (2003) -Link

Employee Responses to Health Insurance Premium Increases (with Arleen A. Leibowitz and David A. Robalino), The American Journal of Managed Care (2004) -Link

Are The Young Becoming More Disabled? (with Darius Lakdawalla and Jayanta Bhattacharya), Health Affairs (2004) -Link

Increased Medicare Expenditures for Physicians' Services: What Are the Causes? (with Melinda J. Beeuwkes Buntin, Jose J. Escarce -Link

The Changing Face of Pharmacy Benefit Design (with Jesse D. Malkin and Geoffrey Joyce), Health Affairs (2004) -Link

Disability Forecasts and Future Medicare Costs (with Jay Bhattacharya , David Cutler, Michael Hurd, Geoff Joyce, Darius Lakdawalla, Constantijn Panis, and Baoping Shang), Frontiers in Health Policy Research (2004)

The Health And Cost Consequences Of Obesity Among The Future Elderly (with Darius Noshir Lakdawalla and Baoping Shang), Health Affairs (2005) -Link

Legal Status And Health Insurance Among Immigrants (with James P. Smith and Neeraj Sood), Health Affairs (2005) -Link

Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-lowering Therapy (with Geoffrey F. Joyce and Karaca-Mandic Karaca-Mandic), The American Journal of Managed Care (2006) -Link

The Value of Elderly Disease Prevention(with David M. Cutler, Baoping Shang, and Geoffrey F. Joyce), Forum for Health Economics & Policy (2006) -Link

Rising Medicare Costs: Are We In Crisis? (with Neeraj Sood), Health Affairs (2006) -Link

Pharmacy Benefits and the Use of Drugs by the Chronically Ill (with Geoffrey F. Joyce, Jose J. Escarce, Jennifer E. Pace, Matthew D. Solomon, Marianne Laouri, Pamela B. Landsman, and Steven M. Teutsch), Journal of the American Medical Association (2006) -Link

Benefit Design And Specialty Drug Use (with Geoffrey F. Joyce, Grant Lawless, William H. Crown, and Vincent Willey), Health Affairs (2006) -Link

Immigrants And The Cost Of Medical Care (with James P. Smith and Neeraj Sood), Health Affairs (2006) -Link

The Promise of Health Care Cost Containment (with Alan Garber and Anupam B. Jena), Health Affairs (2007) -Link

Prescription Drug Cost Sharing (with Geoffrey F. Joyce and Yuhui Zheng), Journal of the American Medical Association (2007)

Drug Licenses: A New Model for Pharmaceutical Pricing (with Anupam B. Jena, Tomas Philipson, and Eric Sun), Health Affairs (2008) -Link

Managed Care as a Public Cost-Containment Mechanism, The RAND Journal of Economics (1995) -Link

The Effects of Benefit Design and Managed Care on Health Care Costs (with Susan D. Hosek, Lloyd S. Dixon, and Elizabeth M. Sloss), Journal of Health Economics (1995) -Link

Cost-Containment and Adverse Selection in Medicaid HMOs (with Arleen Leibowitz and Joan L. Buchanan), Journal of the American Statistical Association (1998) -Link

Queuing for Surgery: Is the U.S. or Canada Worse Off? (with Barton H. Hamilton and Vivian Ho), The Review of Economics and Statistics (2000) -Link

Effect of Insurance on Mortality in an HIV-Positive Population in Care (with Jayanta Bhattacharya, Daniel F. McCaffrey, Naihua Duan, Arleen A. Leibowitz, Geoffrey F. Joyce, and Sally C. Morton), Journal of the American Statistical Association (2001) -Link

Can Patient Self-Management Help Explain the SES Health Gradient? (with James P. Smith), Proceedings of the National Academy of Sciences (2002) -Link

Market Evidence of Misperceived Prices and Mistaken Mortality Risks (with Neeraj Sood and Jayanta Bhattacharya), NBER (2003) -Link

The Link between Public and Private Insurance and HIV-Related Mortality (with Jayanta Bhattacharya and Neeraj Sood), Journal of Health Economics (2003) -Link

Wage and Benefit Changes in Response to Rising Health Insurance (with Neeraj Sood and Arleen Leibowitz), Forum for Health Economics & Policy (2005) -Link

The Reallocation of Compensation in Response to Health Insurance Premium Increases (with Neeraj Sood and Arleen Leibowitz), Economics Letters (2005) -Link

Socioeconomic Differences in the Adoption of New Medical Technologies (with James P. Smith), American Economic Review Papers and Proceedings (2005) -Link

A Theory of Health Disparities and Medical Technology (with Darius Lakdawalla), Contributions to Economic Analysis & Policy (2005) -Link

HIV Treatment and Risky Sexual Behavior (with Darius Lakdawalla and Neeraj Sood), Quarterly Journal of Economics (2005) -Link

Price regulation in secondary insurance markets (with Neeraj Sood and Jay Bhattacharya ), Journal of Risk and Insurance (2005) -Link

HIV Breakthroughs and Risky Sexual Behavior (with Neeraj Sood and Darius Lakdawalla), The Quarterly Journal of Economics (2006) -Link

Adverse Selection in Retiree Prescription Drug Plans (with Dana Goldman, Geoffrey Joyce, Pinar Karaca-Mandic, and Neeraj Sood), Forum for Health Economics & Policy, Forum: Frontiers in Health Policy Research (2006) -Link

Adverse Selection in Retiree Prescription Drug Plans (with Geoffrey Joyce, Pinar Karaca-Mandic, and Neeraj Sood), Forum for Health Economics & Policy (2006) -Link

Adverse Selection in Prescription Drug Plans, Forum for Health Economics & Policy (2007) -Link

Pharmacy Benefit Caps And the Chronically Ill(with Geoffrey F. Joyce, Dana P. Goldman, Pinar Karaca-Mandic, and Yuhui Zheng), Health Affairs (2007)" -Link

Does Age or Life Expectancy Better Predict Health Care Expenditures? (with Baoping Shang), Health Economics (2007) -Link

Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000, Economists' Voice (2008) -Link

Impact of Specialty Drugs on the Use of Other Medical Services (with Geoffrey F. Joyce, Pinar Karaca-Mandic, and Grant D. Lawless), American Journal of Managed Care (2008) -Link